Mitochondrial reprogramming in triple negative breast cancer progression

被引：0
|
作者：
Park, Junhyoung [1 ]
Arora, Kavisha [1 ]
Vithayathil, Sajna A. [1 ]
Donti, Taraka R. [1 ]
Creighton, Chad [1 ]
Lewis, Michael T. [1 ]
Sreekumar, Arun [1 ]
Wong, Lee-Jun [1 ]
Kaipparettu, Benny A. [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-4327
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4327
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Mitochondrial reprogramming regulated cancer pathway in triple negative breast cancer
    Park, Jun H.
    Vithayathil, Sajna
    Wu, Danli
    Putluri, Vasanta
    Sung, Pi-Lin
    Tsouko, Efrosini
    Bhat, Vadiraja B.
    Coarfa, Cristian
    Frigo, Daniel E.
    Lewis, Michael T.
    Sreekumar, Arun
    Yotnda, Patricia
    Creighton, Chad J.
    Putluri, Nagireddy
    Wong, Lee-Jun C.
    Kaipparettu, Benny A.
    CANCER RESEARCH, 2016, 76
  • [2] Activation of oncogenic pathways by mitochondrial reprogramming in triple negative breast cancer
    Park, Jun Hyoung
    Kumar, Santhosh
    Vithayathil, Sajna
    Arora, Kavisha
    Putluri, Nagireddy
    Tsouko, Efrosini
    Donti, Taraka R.
    Frigo, Daniel E.
    Creighton, Chad J.
    Lewis, Michael T.
    Sreekumar, Arun
    Wong, Lee-Jun
    Kaipparettu, Benny Abraham
    CANCER RESEARCH, 2015, 75
  • [3] Mitochondrial Reprogramming Regulates Breast Cancer Progression
    Kannan, Anbarasu
    Wells, Robert B.
    Sivakumar, Subramaniam
    Komatsu, Satoshi
    Singh, Karan P.
    Samten, Buka
    Philley, Julie V.
    Sauter, Edward R.
    Ikebe, Mitsuo
    Idell, Steven
    Gupta, Sudeep
    Dasgupta, Santanu
    CLINICAL CANCER RESEARCH, 2016, 22 (13) : 3348 - 3360
  • [4] Metabolic Reprogramming in Triple-Negative Breast Cancer
    Sun Xiangyu
    Wang Mozhi
    Wang Mengshen
    Yu Xueting
    Guo Jingyi
    Sun Tie
    Li Xinyan
    Yao Litong
    Dong Haoran
    Xu Yingying
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [5] Metabolic reprogramming in triple-negative breast cancer
    Zhanyu Wang
    Qianjin Jiang
    Chenfang Dong
    Cancer Biology & Medicine , 2020, (01) : 44 - 59
  • [6] Metabolic reprogramming in triple-negative breast cancer
    Zhanyu Wang
    Qianjin Jiang
    Chenfang Dong
    Cancer Biology & Medicine, 2020, 17 (01) : 44 - 59
  • [7] Metabolic reprogramming in triple-negative breast cancer
    Wang, Zhanyu
    Jiang, Qianjin
    Dong, Chenfang
    CANCER BIOLOGY & MEDICINE, 2020, 17 (01) : 44 - 59
  • [8] Sulindac and triple negative breast cancer progression
    Xi, Y.
    Yi, B.
    Riker, A.
    CANCER RESEARCH, 2019, 79 (04)
  • [9] Tunicamycin inhibits triple negative breast cancer progression
    Banerjee, Aditi
    Duran, Elizabeth
    Couto, Javier A.
    Zhang, Zhenbo
    Espinoza, Lydia A.
    Banerjee, Sushanta K.
    Baksi, Krishna
    Banerjee, Dipak K.
    CANCER RESEARCH, 2011, 71
  • [10] Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) promotes progression of triple negative breast cancer
    Tsai, Huijen
    Chang, Tsungming
    Hsu, Huiping
    Chu, Peiyi
    Huang, Kuowei
    Jiang, Shihsheng
    Lin, Huiyou
    CANCER SCIENCE, 2024, 115 : 1536 - 1536
12345